Publications

1. 

Amyloid-related default mode network hyperconnectivity and longitudinal decline in network distinctiveness in preclinical Alzheimer’s disease. 

Cha WJ, Chumin EJ, Yi D, Byun MS, Jung JH, Ahn H, Jung G, Kim YK, Lee YS, Kang KM, Sohn CH, Risacher SL, Sporns O, Nho K, Saykin AJ, Lee DY; KBASE Research Group.

Alzheimers Dement. 2026 Feb;22(2):e71025. doi: 10.1002/alz.71025.

PMID: 41612924      Free PMC article.      

2. 

Longitudinal brain morphometry in Parkinson’s disease clinical subtypes: Distinct signatures forecast behavioral change within subtypes. 

Eid AM, Grossen S, Tanenbaum A, Hwang H, Cash TV, Franklin EE, Maiti B, Foster ER, Lessov-Schlaggar CN, Perrin RJ, Jackson JJ, Kotzbauer PT, Perlmutter JS, Campbell MC.

Parkinsonism Relat Disord. 2026 Jan;142:108141. doi: 10.1016/j.parkreldis.2025.108141. Epub 2025 Dec 6.

PMID: 41371075      Free PMC article.      

3. 

Polygenic risk score predicts pathologically confirmed cerebral amyloid angiopathy. 

Pyun JM, Park YH, Kim S, Nho K; Alzheimer’s Disease Neuroimaging Initiative.

Alzheimers Dement. 2025 Dec;21(12):e70958. doi: 10.1002/alz.70958.

PMID: 41383049      Free PMC article.      

4. 

Integrative multi-omics approaches identify molecular pathways and improve Alzheimer’s disease risk prediction. 

Venkatesh R, Cardone KM, Bradford Y, Moore AK, Kumar R, Moore JH, Shen L, Kim D, Ritchie MD.

Alzheimers Dement. 2025 Nov;21(11):e70886. doi: 10.1002/alz.70886.

PMID: 41231230      Free PMC article.      

5. 

Artificial Clinic Intelligence (ACI): A Generative AI-Powered Modeling Platform to Optimize Patient Cohort Enrichment and Clinical Trial Optimization. 

Ung CY, Correia C, Zhang Z, Caya C, Zhu S, Billadeau DD, Li H.

Cancers (Basel). 2025 Nov 1;17(21):3543. doi: 10.3390/cancers17213543.

PMID: 41228335      Free PMC article.      

6. 

Cerebrospinal fluid proteins in relation to longitudinal cognitive trajectories. 

Kim BH, Seo SW, Kim J, Nho K; Alzheimer’s Disease Neuroimaging Initiative#.

Alzheimers Dement. 2025 Nov;21(11):e70894. doi: 10.1002/alz.70894.

PMID: 41216795      Free PMC article.      

7. 

Uncertainty-aware genomic classification of Alzheimer’s disease: a transformer-based ensemble approach with Monte Carlo dropout. 

Jo T, Lee EH; Alzheimer s Disease Neuroimaging Initiative (ADNI) and the Alzheimer s Disease Sequencing Project (ADSP).

Brief Bioinform. 2025 Nov 1;26(6):bbaf587. doi: 10.1093/bib/bbaf587.

PMID: 41212591      Free PMC article.      

8. 

Real-world observations on neuroinflammation-related drug responses in Alzheimer’s disease. 

Xu J, Sun A, Yang Y, Shi Y, Lai D, Su J, Li L, Zeng D, Saykin AJ, Cheng F, Liu Y, Zhang P.

J Alzheimers Dis. 2025 Nov;108(1):273-280. doi: 10.1177/13872877251376291. Epub 2025 Sep 12.

PMID: 40938773      Free PMC article.      

9. 

Longitudinal non-linear changes in the microstructure of the hippocampal subfields in older adults. 

Zia G, Shahid SS, Yang HC, Gao S, Risacher SL, Saykin AJ, Wu YC.

Neurobiol Aging. 2025 Nov;155:113-123. doi: 10.1016/j.neurobiolaging.2025.07.008. Epub 2025 Jul 12.

PMID: 40752038      Free PMC article.      

10. 

Plasma proteomic Alzheimer’s risk score: Biological age clock and pseudotime trajectory. 

Liu S, Huang YN, Park T, Lee EH, Chaudhuri S, Adzibolosu N, Bice PJ, Dage JL, Brosch JR, Gao S, Apostolova LG, Wilcock DM, Risacher SL, Saykin AJ, Nho K.

Alzheimers Dement. 2025 Oct;21(10):e70851. doi: 10.1002/alz.70851.

PMID: 41157910      Free PMC article.      

11. 

The Cognitive Change Index in the Alzheimer’s Disease Research Center setting: Self- and informant-ratings for perceived cognitive decline. 

Abughofah Y, Risacher SL, Unverzagt FW, Farlow MR, Apostolova LG, Brosch JR, Clark DG, Mathew S, Gao S, Wang S, Wang S, Saykin AJ.

Alzheimers Dement. 2025 Oct;21(10):e70754. doi: 10.1002/alz.70754.

PMID: 41027849      Free PMC article.      

12. 

JASMINE: A powerful representation learning method for enhanced analysis of incomplete multi-omics data. 

Ballard JL, Dai Z, Shen L, Long Q; Alzheimer s Disease Neuroimaging Initiative; Alzheimer s Disease Metabolomics Consortium.

bioRxiv [Preprint]. 2025 Sep 9:2025.06.16.659949. doi: 10.1101/2025.06.16.659949.

PMID: 40666922      Free PMC article.      Preprint.      

13. 

TrimNN: characterizing cellular community motifs for studying multicellular topological organization in complex tissues. 

Yu Y, Wang S, Li J, Yu M, McCrocklin K, Kang JQ, Ma A, Ma Q, Xu D, Wang J.

Nat Commun. 2025 Aug 19;16(1):7737. doi: 10.1038/s41467-025-63141-7.

PMID: 40830137      Free PMC article.      

14. 

Deep fusion of incomplete multi-omic data for molecular mechanism of Alzheimer’s disease. 

Xie L, Raj Y, Tong M, Nho K, Salama P, Saykin AJ, Fang S, Yan J.

Sci Rep. 2025 Aug 18;15(1):30182. doi: 10.1038/s41598-025-14636-2.

PMID: 40825989      Free PMC article.      

15. 

Plasma proteomic analysis identifies proteins and pathways related to Alzheimer’s risk. 

Huang YN, Liu S, Park T, Chaudhuri S, Kuchenbecker LA, Carrasquillo MM, Ertekin-Taner N, Bice PJ, Zetterberg H, Blennow K, Russ K, Dage JL, Nudelman KNH, Cruchaga C, Brosch JR, Farlow MR, Clark DG, Mathew S, Unverzagt F, Gao S, Wang S, Apostolova LG, Wilcock DM, Foroud T, Risacher SL, Saykin AJ, Nho K.

Alzheimers Dement. 2025 Aug;21(8):e70579. doi: 10.1002/alz.70579.

PMID: 40810263      Free PMC article.      

16. 

Trajectory of plasma lipidome associated with the risk of late-onset Alzheimer’s disease: a longitudinal cohort study. 

Wang T, Arnold M, Huynh K, Weinisch P, Giles C, Mellett NA, Duong T, Marella B, Nho K, De Livera A, Han X, Blach C, Yu C, McNeil JJ, Lacaze P, Saykin AJ, Kastenm ller G, Meikle PJ, Kaddurah-Daouk R; Alzheimer’s Disease Neuroimaging Initiative (ADNI).

EBioMedicine. 2025 Aug;118:105826. doi: 10.1016/j.ebiom.2025.105826. Epub 2025 Jun 30.

PMID: 40592256      Free PMC article.      

17. 

Protein-based Diagnosis and Analysis of Co-pathologies Across Neurodegenerative Diseases: Large-Scale AI-Boosted CSF and Plasma Classification. 

Xu Y, Western D, Heo G, Nho K, Huang YN, Liu S, Oh HS, Chen Y, Timsina J, Liu M, Tang Y, Gong K, Budde J, Krish V, Imam F, Fuentes RP, Cano A, Marquie M, Boada M; Knight Alzheimer Disease Research Center (Knight-ADRC); Dominantly Inherited Alzheimer Network (DIAN); Alzheimer Disease Neuroimaging Initiative (ADNI); ACE Alzheimer Center Barcelona (ACE); Barcelona-1; Stanford Alzheimer Disease Research Center (Stanford-ADRC); Global Neurodegeneration Proteomics Consortium (GNPC); Pastor P, Ruiz A, Fern ndez MV, Bennett D, Klein G, Wyss-Coray T, Saykin AJ, Ali M, Cruchaga C.

Res Sq [Preprint]. 2025 Jul 31:rs.3.rs-6933762. doi: 10.21203/rs.3.rs-6933762/v1.

PMID: 40766224      Free PMC article.      Preprint.      

18. 

miR-423-5p and miR-92a-3p in Alzheimer’s disease: relationship with pathology and cognition. 

Han SW, Park YH, Pyun JM, Bice PJ, Kim S, Saykin AJ, Nho K.

Front Aging Neurosci. 2025 Jul 22;17:1637368. doi: 10.3389/fnagi.2025.1637368. eCollection 2025.

PMID: 40766177      Free PMC article.      

19. 

Multi-omics analysis for identifying cell-type-specific and bulk-level druggable targets in Alzheimer’s disease. 

Liu S, Cho M, Huang YN, Park T, Chaudhuri S, Rosewood TJ, Bice PJ, Chung D, Bennett DA, Ertekin-Taner N, Saykin AJ, Nho K.

J Transl Med. 2025 Jul 13;23(1):788. doi: 10.1186/s12967-025-06739-1.

PMID: 40653482      Free PMC article.      

20. 

Protein-based Diagnosis and Analysis of Co-pathologies Across Neurodegenerative Diseases: Large-Scale AI-Boosted CSF and Plasma Classification. 

Xu Y, Western D, Heo G, Nho K, Huang YN, Liu S, Oh HS, Chen Y, Timsina J, Liu M, Tang Y, Gong K, Budde J, Krish V, Imam F, Fuentes RP, Cano A, Marquie M, Boada M; Knight Alzheimer Disease Research Center (Knight-ADRC), Dominantly Inherited Alzheimer Network (DIAN), Alzheimer Disease Neuroimaging Initiative (ADNI), ACE Alzheimer Center Barcelona (ACE), Barcelona-1, Stanford Alzheimer Disease Research Center (Stanford-ADRC), The Global Neurodegeneration Proteomics Consortium (GNPC); Pastor P, Ruiz A, Fern ndez MV, Bennett D, Wyss-Coray T, Saykin AJ, Ali M, Cruchaga C.

medRxiv [Preprint]. 2025 Jul 10:2025.07.09.25331192. doi: 10.1101/2025.07.09.25331192.

PMID: 40672487      Free PMC article.      Preprint.      

21. 

Tau-seed interactome analysis reveals distinct functional signatures in Alzheimer’s disease across model systems. 

Martinez P, Patel H, You Y, Lopes D, Amaro A, Jury-Garfe N, Min Y, Redding-Ochoa J, Dutta S, Rochet JC, Ertekin-Taner N, Troncoso JC, Lasagna-Reeves CA.

bioRxiv [Preprint]. 2025 Jun 20:2025.06.17.660179. doi: 10.1101/2025.06.17.660179.

PMID: 40666999      Free PMC article.      Preprint.      

22. 

SLR: A Modified Logistic Regression Model with Sinkhorn Divergence for Alzheimer’s Disease Classification. 

Zhan Q, Zhou Z, Wen Z, Wang Z, Tong B, Huang H, Saykin AJ, Thompson PM, Davatzikos C, Shen L.

AMIA Jt Summits Transl Sci Proc. 2025 Jun 10;2025:634-643. eCollection 2025.

PMID: 40502270      Free PMC article.      

23. 

Sex-Based Differences in the Association of Epigenetic Age Acceleration with Alzheimer’s Disease Biomarkers and Cognitive Measures. 

Edwards TA, Zhai T, Nho K, Saykin AJ, Long Q, Shen L.

AMIA Jt Summits Transl Sci Proc. 2025 Jun 10;2025:141-148. eCollection 2025.

PMID: 40502223      Free PMC article.      

24. 

Integrative multi-omics approaches identify molecular pathways and improve Alzheimer’s Disease risk prediction. 

Venkatesh R, Cardone KM, Bradford Y, Moore AK, Kumar R, Moore JH, Shen L, Kim D, Ritchie MD.

medRxiv [Preprint]. 2025 Jun 2:2025.05.31.25328688. doi: 10.1101/2025.05.31.25328688.

Update in: Alzheimers Dement. 2025 Nov;21(11):e70886. doi: 10.1002/alz.70886.

PMID: 40502591      Free PMC article.      Preprint.      

25. 

Anxious-depressive symptoms and sleep disturbances across the Alzheimer disease spectrum. 

Chai Y, Shokri-Kojori E, Saykin AJ, Yu M.

Nat Ment Health. 2025 Jun;3(6):594-612. doi: 10.1038/s44220-025-00416-4. Epub 2025 May 28.

PMID: 40964168      Free PMC article.      

26. 

The dynamics of cognitive decline toward Alzheimer’s disease progression: Results from ADSP-PHC’s harmonized cognitive composites. 

Kang K, Zhang P, Dumitrescu L, Mukherjee S, Lee ML, Choi SE, Trittschuh EH, Mez J, Saykin AJ, Gifford KA, Buckley RF, Gao X, Di J, Crane PK, Hohman TJ, Liu D.

Alzheimers Dement. 2025 Jun;21(6):e70335. doi: 10.1002/alz.70335.

PMID: 40538025      Free PMC article.      

27. 

Leveraging multivariate information for community detection in functional brain networks. 

Puxeddu MG, Pope M, Varley TF, Faskowitz J, Sporns O.

Commun Biol. 2025 May 30;8(1):840. doi: 10.1038/s42003-025-08198-2.

PMID: 40447780      Free PMC article.      

28. 

Identification and Validation of New Molecular Subtypes within the Early and Late Mild Cognitive Impairment Stages of Alzheimer’s Disease. 

Li B, Yadav S, Zhou S, Du Y, Qian L, Karas Z, Zhang Y, Shen L, Lee JJ, Vardarajan BN, Lee AJ, Garmire LX; Alzheimer s Disease Neuroimaging Initiative (ADNI).

medRxiv [Preprint]. 2025 May 24:2023.04.06.23288268. doi: 10.1101/2023.04.06.23288268.

PMID: 40475149      Free PMC article.      Preprint.      

29. 

Knowledge-Driven Feature Selection and Engineering for Genotype Data with Large Language Models. 

Lee J, Yang S, Baik JY, Liu X, Tan Z, Li D, Wen Z, Hou B, Duong-Tran D, Chen T, Shen L.

ArXiv [Preprint]. 2025 Apr 16:arXiv:2410.01795v2.

Update in: AMIA Jt Summits Transl Sci Proc. 2025 Jun 10;2025:250-259.

PMID: 40321944      Free PMC article.      Preprint.      

30. 

Multi Layered Omics Approaches Reveal Glia Specific Alterations in Alzheimer’s Disease: A Systematic Review and Future Prospects. 

İş , Min Y, Wang X, Oatman SR, Abraham Daniel A, Ertekin-Taner N.

Glia. 2025 Mar;73(3):539-573. doi: 10.1002/glia.24652. Epub 2024 Dec 9.

PMID: 39652363      Free PMC article.      

31. 

Transcriptome analysis of early- and late-onset Alzheimer’s disease in Korean cohorts. 

Han SW, Hwang J, Park T, Pyun JM, Lee JY, Park JS, Bice PJ, Liu S, Yun S, Jeong J, Risacher SL, Saykin AJ, Byun MS, Yi D, Sung J, Lee DY, Kim S, Nho K, Park YH.

Alzheimers Dement. 2025 Feb;21(2):e14563. doi: 10.1002/alz.14563.

PMID: 39935412      Free PMC article.      

32. 

Locus coeruleus tau is linked to successive cortical tau accumulation. 

Yi D, Byun MS, Jung JH, Jung G, Ahn H, Chang YY, Keum M, Lee JY, Lee YS, Kim YK, Kang KM, Sohn CH, Risacher SL, Saykin AJ, Lee DY; KBASE Research Group.

Alzheimers Dement. 2025 Feb;21(2):e14426. doi: 10.1002/alz.14426. Epub 2024 Dec 6.

PMID: 39641328      Free PMC article.      

33. 

Tau pathway-based gene analysis on PET identifies CLU and FYN in a Korean cohort. 

Yi D, Byun MS, Park JH, Kim JW, Jung G, Ahn H, Lee JY, Lee YS, Kim YK, Kang KM, Sohn CH, Liu S, Huang YN, Saykin AJ, Lee DY, Nho K; KBASE research group.

Alzheimers Dement. 2025 Feb;21(2):e14416. doi: 10.1002/alz.14416. Epub 2024 Dec 3.

PMID: 39625110      Free PMC article.      

34. 

Parallel median consensus clustering in complex networks. 

Hussain MT, Halappanavar M, Chatterjee S, Radicchi F, Fortunato S, Azad A.

Sci Rep. 2025 Jan 30;15(1):3788. doi: 10.1038/s41598-025-87479-6.

PMID: 39885235      Free PMC article.      

35. 

TrimNN: Characterizing cellular community motifs for studying multicellular topological organization in complex tissues. 

Yu Y, Wang S, Li J, Yu M, McCrocklin K, Kang JQ, Ma A, Ma Q, Xu D, Wang J.

Res Sq [Preprint]. 2025 Jan 17:rs.3.rs-5584635. doi: 10.21203/rs.3.rs-5584635/v1.

Update in: Nat Commun. 2025 Aug 19;16(1):7737. doi: 10.1038/s41467-025-63141-7.

PMID: 39877090      Free PMC article.      Preprint.      

36. 

LD-informed deep learning for Alzheimer’s gene loci detection using WGS data. 

Jo T, Bice P, Nho K, Saykin AJ; Alzheimer’s Disease Sequencing Project.

Alzheimers Dement (N Y). 2025 Jan 16;11(1):e70041. doi: 10.1002/trc2.70041. eCollection 2025 Jan-Mar.

PMID: 39822590      Free PMC article.      

37. 

Multi-Omics Analysis for Identifying Cell-Type-Specific Druggable Targets in Alzheimer’s Disease. 

Liu S, Cho MY, Huang YN, Park T, Chaudhuri S, Rosewood TJ, Bice PJ, Chung D, Bennett DA, Ertekin-Taner N, Saykin AJ, Nho K.

medRxiv [Preprint]. 2025 Jan 9:2025.01.08.25320199. doi: 10.1101/2025.01.08.25320199.

Update in: J Transl Med. 2025 Jul 13;23(1):788. doi: 10.1186/s12967-025-06739-1.

PMID: 39830273      Free PMC article.      Preprint.      

38. 

Comprehensive characterization of the transcriptional landscape in Alzheimer’s disease (AD) brains. 

Chen C, Zhang Z, Liu Y, Hong W, Karahan H, Wang J, Li W, Diao L, Yu M, Saykin AJ, Nho K, Kim J, Han L.

Sci Adv. 2025 Jan 3;11(1):eadn1927. doi: 10.1126/sciadv.adn1927. Epub 2025 Jan 3.

PMID: 39752483      Free PMC article.      

39. 

A DAT1 gene and APOE ε4 interaction is associated with apathy and structural brain changes in mild cognitive impairment and Alzheimer’s disease. 

Malik R, Beaton D, Ahmed J, Nho K, Saykin AJ, Wang J, Hegele RA, Finger E; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2025 Jan;103(1):230-242. doi: 10.1177/13872877241299785. Epub 2024 Nov 29.

PMID: 39610284      Free PMC article.      

40. 

LD-informed deep learning for Alzheimer’s gene loci detection using WGS data. 

Jo T, Bice P, Nho K, Saykin AJ; Alzheimer s Disease Sequencing Project.

medRxiv [Preprint]. 2024 Dec 12:2024.09.19.24313993. doi: 10.1101/2024.09.19.24313993.

Update in: Alzheimers Dement (N Y). 2025 Jan 16;11(1):e70041. doi: 10.1002/trc2.70041.

PMID: 39371140      Free PMC article.      Preprint.      

41. 

Cell Type Differentiation Using Network Clustering Algorithms. 

Nasrollahi FSF, Silva FN, Liu S, Chaudhuri S, Yu M, Wang J, Nho K, Saykin AJ, Bennett DA, Sporns O, Fortunato S.

bioRxiv [Preprint]. 2024 Dec 7:2024.12.04.626793. doi: 10.1101/2024.12.04.626793.

PMID: 39677670      Free PMC article.      Preprint.      

42. 

Repurposing FDA-Approved Drugs Against Potential Drug Targets Involved in Brain Inflammation Contributing to Alzheimer’s Disease. 

Sharo C, Zhang J, Zhai T, Bao J, Garcia-Epelboim A, Mamourian E, Shen L, Huang Z.

Targets (Basel). 2024 Dec;2(4):446-469. doi: 10.3390/targets2040025. Epub 2024 Dec 4.

PMID: 39897171      Free PMC article.      

43. 

Large-scale deep proteomic analysis in Alzheimer’s disease brain regions across race and ethnicity. 

Seifar F, Fox EJ, Shantaraman A, Liu Y, Dammer EB, Modeste E, Duong DM, Yin L, Trautwig AN, Guo Q, Xu K, Ping L, Reddy JS, Allen M, Quicksall Z, Heath L, Scanlan J, Wang E, Wang M, Linden AV, Poehlman W, Chen X, Baheti S, Ho C, Nguyen T, Yepez G, Mitchell AO, Oatman SR, Wang X, Carrasquillo MM, Runnels A, Beach T, Serrano GE, Dickson DW, Lee EB, Golde TE, Prokop S, Barnes LL, Zhang B, Haroutunian V, Gearing M, Lah JJ, De Jager P, Bennett DA, Greenwood A, Ertekin-Taner N, Levey AI, Wingo A, Wingo T, Seyfried NT.

Alzheimers Dement. 2024 Dec;20(12):8878-8897. doi: 10.1002/alz.14360. Epub 2024 Nov 13.

PMID: 39535480      Free PMC article.      

44. 

Genome-wide transcriptome analysis of Aβ deposition on PET in a Korean cohort. 

Park T, Hwang J, Liu S, Chaudhuri S, Han SW, Yi D, Byun MS, Huang YN, Rosewood T, Jung G, Kim MJ, Ahn H, Lee JY, Kim YK, Cho M, Bice PJ, Craft H, Risacher SL, Gao H, Liu Y, Kim S, Park YH, Lee DY, Saykin AJ, Nho K.

Alzheimers Dement. 2024 Dec;20(12):8787-8801. doi: 10.1002/alz.14348. Epub 2024 Nov 8.

PMID: 39513963      Free PMC article.      

45. 

Association of amyloid and cardiovascular risk with cognition: Findings from KBASE. 

Chaudhuri S, Dempsey DA, Huang YN, Park T, Cao S, Chumin EJ, Craft H, Crane PK, Mukherjee S, Choi SE, Scollard P, Lee M, Nakano C, Mez J, Trittschuh EH, Klinedinst BS, Hohman TJ, Lee JY, Kang KM, Sohn CH, Kim YK, Yi D, Byun MS, Risacher SL, Nho K, Saykin AJ, Lee DY; KBASE Research Group.

Alzheimers Dement. 2024 Dec;20(12):8527-8540. doi: 10.1002/alz.14290. Epub 2024 Nov 7.

PMID: 39511852      Free PMC article.      

46. 

Pathway enrichment in genome-wide analysis of longitudinal Alzheimer’s disease biomarker endophenotypes. 

Rosewood TJ, Nho K, Risacher SL, Liu S, Gao S, Shen L, Foroud T, Saykin AJ; Alzheimer’s Disease Neuroimaging Initiative.

Alzheimers Dement. 2024 Dec;20(12):8639-8650. doi: 10.1002/alz.14308. Epub 2024 Oct 23.

PMID: 39440837      Free PMC article.      

47. 

Comparative brain metabolomics reveals shared and distinct metabolic alterations in Alzheimer’s disease and progressive supranuclear palsy. 

Batra R, Krumsiek J, Wang X, Allen M, Blach C, Kastenm ller G, Arnold M, Ertekin-Taner N, Kaddurah-Daouk R; Alzheimer’s Disease Metabolomics Consortium (ADMC).

Alzheimers Dement. 2024 Dec;20(12):8294-8307. doi: 10.1002/alz.14249. Epub 2024 Oct 22.

PMID: 39439201      Free PMC article.      

48. 

Nuclear receptor-SINE B1 network modulates expanded pluripotency in blastoids and blastocysts. 

Wong KW, Zeng Y, Tay E, Teo JHJ, Cipta NO, Hamashima K, Yi Y, Liu H, Warrier T, Le MTN, Ng SC, Li QJ, Li H, Loh YH.

Nat Commun. 2024 Nov 19;15(1):10011. doi: 10.1038/s41467-024-54381-0.

PMID: 39562549      Free PMC article.      

49. 

Deciphering the tissue-specific functional effect of Alzheimer risk SNPs with deep genome annotation. 

Pugalenthi PV, He B, Xie L, Nho K, Saykin AJ, Yan J.

BioData Min. 2024 Nov 13;17(1):50. doi: 10.1186/s13040-024-00400-1.

PMID: 39538253      Free PMC article.      

50. 

TIA1 Mediates Divergent Inflammatory Responses to Tauopathy in Microglia and Macrophages. 

Webber CJ, van de Spek SJF, Cruz AL, Puri S, Zhang C, Aw JTM, Papadimitriou GZ, Roberts R, Jiang K, Tran TN, Zhang L, Taylor A, Wang Z, Porter J, Sotiropoulos I, Emili A, Silva J, Li H, Wolozin B.

bioRxiv [Preprint]. 2024 Nov 7:2024.11.06.622325. doi: 10.1101/2024.11.06.622325.

PMID: 39574689      Free PMC article.      Preprint.      

51. 

Network community detection via neural embeddings. 

Kojaku S, Radicchi F, Ahn YY, Fortunato S.

Nat Commun. 2024 Nov 1;15(1):9446. doi: 10.1038/s41467-024-52355-w.

PMID: 39487114      Free PMC article.      

52. 

GWAS of multiple neuropathology endophenotypes identifies new risk loci and provides insights into the genetic risk of dementia. 

Shade LMP, Katsumata Y, Abner EL, Aung KZ, Claas SA, Qiao Q, Heberle BA, Brandon JA, Page ML, Hohman TJ, Mukherjee S, Mayeux RP, Farrer LA, Schellenberg GD, Haines JL, Kukull WA, Nho K, Saykin AJ, Bennett DA, Schneider JA; National Alzheimer s Coordinating Center; Alzheimer s Disease Genetics Consortium; Ebbert MTW, Nelson PT, Fardo DW.

Nat Genet. 2024 Nov;56(11):2407-2421. doi: 10.1038/s41588-024-01939-9. Epub 2024 Oct 8.

PMID: 39379761      Free PMC article.      

53. 

The plasma miRNAome in ADNI: Signatures to aid the detection of at-risk individuals. 

Kr ger DM, Pena-Centeno T, Liu S, Park T, Kaurani L, Pradhan R, Huang YN, Risacher SL, Burkhardt S, Sch tz AL, Wan Y, Shaw LM, Brodsky AS, DeStefano AL, Lin H, Schroeder R, Krunic A, Hempel N, Sananbenesi F, Blusztajn JK, Saykin AJ, Delalle I, Nho K, Fischer A; Alzheimer’s Disease Neuroimaging Initiative.

Alzheimers Dement. 2024 Nov;20(11):7479-7494. doi: 10.1002/alz.14157. Epub 2024 Sep 18.

PMID: 39291752      Free PMC article.      

54. 

Plasma miRNAs across the Alzheimer’s disease continuum: Relationship to central biomarkers. 

Liu S, Park T, Kr ger DM, Pena-Centeno T, Burkhardt S, Schutz AL, Huang YN, Rosewood T, Chaudhuri S, Cho M, Risacher SL, Wan Y, Shaw LM, Sananbenesi F, Brodsky AS, Lin H, Krunic A, Blusztajn JK, Saykin AJ, Delalle I, Fischer A, Nho K; Alzheimer’s Disease Neuroimaging Initiative.

Alzheimers Dement. 2024 Nov;20(11):7698-7714. doi: 10.1002/alz.14230. Epub 2024 Sep 18.

PMID: 39291737      Free PMC article.      

55. 

Integrating amyloid imaging and genetics for early risk stratification of Alzheimer’s disease. 

He B, Wu R, Sangani N, Pugalenthi PV, Patania A, Risacher SL, Nho K, Apostolova LG, Shen L, Saykin AJ, Yan J; Alzheimer’s Disease Neuroimaging Initiative.

Alzheimers Dement. 2024 Nov;20(11):7819-7830. doi: 10.1002/alz.14244. Epub 2024 Sep 17.

PMID: 39285750      Free PMC article.      

56. 

Bridging the gap: Multi-omics profiling of brain tissue in Alzheimer’s disease and older controls in multi-ethnic populations. 

Reddy JS, Heath L, Linden AV, Allen M, Lopes KP, Seifar F, Wang E, Ma Y, Poehlman WL, Quicksall ZS, Runnels A, Wang Y, Duong DM, Yin L, Xu K, Modeste ES, Shantaraman A, Dammer EB, Ping L, Oatman SR, Scanlan J, Ho C, Carrasquillo MM, Atik M, Yepez G, Mitchell AO, Nguyen TT, Chen X, Marquez DX, Reddy H, Xiao H, Seshadri S, Mayeux R, Prokop S, Lee EB, Serrano GE, Beach TG, Teich AF, Haroutunian V, Fox EJ, Gearing M, Wingo A, Wingo T, Lah JJ, Levey AI, Dickson DW, Barnes LL, De Jager P, Zhang B, Bennett D, Seyfried NT, Greenwood AK, Ertekin-Taner N.

Alzheimers Dement. 2024 Oct;20(10):7174-7192. doi: 10.1002/alz.14208. Epub 2024 Aug 30.

PMID: 39215503      Free PMC article.      

57. 

Age-Specific Barriers and Facilitators to Research Participation Amongst African Americans in Observational Studies of Memory and Aging. 

Nissim NR, Fudge MR, Lachner C, Babulal GM, Allyse MA, Graff-Radford NR, Lucas JA, Day GS.

J Racial Ethn Health Disparities. 2024 Oct;11(5):2796-2805. doi: 10.1007/s40615-023-01741-z. Epub 2023 Aug 9.

PMID: 37555913      Free PMC article.      

58. 

CYP1B1-RMDN2 Alzheimer’s disease endophenotype locus identified for cerebral tau PET. 

Nho K, Risacher SL, Apostolova LG, Bice PJ, Brosch JR, Deardorff R, Faber K, Farlow MR, Foroud T, Gao S, Rosewood T, Kim JP, Nudelman K, Yu M, Aisen P, Sperling R, Hooli B, Shcherbinin S, Svaldi D, Jack CR Jr, Jagust WJ, Landau S, Vasanthakumar A, Waring JF, Dor V, Laws SM, Masters CL, Porter T, Rowe CC, Villemagne VL, Dumitrescu L, Hohman TJ, Libby JB, Mormino E, Buckley RF, Johnson K, Yang HS, Petersen RC, Ramanan VK, Ertekin-Taner N, Vemuri P, Cohen AD, Fan KH, Kamboh MI, Lopez OL, Bennett DA, Ali M, Benzinger T, Cruchaga C, Hobbs D, De Jager PL, Fujita M, Jadhav V, Lamb BT, Tsai AP, Castanho I, Mill J, Weiner MW; Alzheimer s Disease Neuroimaging Initiative (ADNI); Department of Defense Alzheimer s Disease Neuroimaging Initiative (DoD-ADNI); Anti-Amyloid Treatment in Asymptomatic Alzheimer s Study (A4 Study) and Longitudinal Evaluation of Amyloid Risk and Neurodegeneration (LEARN); Australian Imaging, Biomarker & Lifestyle Study (AIBL); Saykin AJ.

Nat Commun. 2024 Sep 20;15(1):8251. doi: 10.1038/s41467-024-52298-2.

PMID: 39304655      Free PMC article.      

59. 

ABCA7-dependent induction of neuropeptide Y is required for synaptic resilience in Alzheimer’s disease through BDNF/NGFR signaling. 

Tayran H, Yilmaz E, Bhattarai P, Min Y, Wang X, Ma Y, Wang N, Jeong I, Nelson N, Kassara N, Cosacak MI, Dogru RM, Reyes-Dumeyer D, Stenersen JM, Reddy JS, Qiao M, Flaherty D, Gunasekaran TI, Yang Z, Jurisch-Yaksi N, Teich AF, Kanekiyo T, Tosto G, Vardarajan BN, İş , Ertekin-Taner N, Mayeux R, Kizil C.

Cell Genom. 2024 Sep 11;4(9):100642. doi: 10.1016/j.xgen.2024.100642. Epub 2024 Aug 30.

PMID: 39216475      Free PMC article.      

60. 

Integrative proteomics identifies a conserved Aβ amyloid responsome, novel plaque proteins, and pathology modifiers in Alzheimer’s disease. 

Levites Y, Dammer EB, Ran Y, Tsering W, Duong D, Abreha M, Gadhavi J, Lolo K, Trejo-Lopez J, Phillips J, Iturbe A, Erquizi A, Moore BD, Ryu D, Natu A, Dillon K, Torrellas J, Moran C, Ladd T, Afroz F, Islam T, Jagirdar J, Funk CC, Robinson M, Rangaraju S, Borchelt DR, Ertekin-Taner N, Kelly JW, Heppner FL, Johnson ECB, McFarland K, Levey AI, Prokop S, Seyfried NT, Golde TE.

Cell Rep Med. 2024 Aug 20;5(8):101669. doi: 10.1016/j.xcrm.2024.101669. Epub 2024 Aug 9.

PMID: 39127040      Free PMC article.      

61. 

MAPT haplotype-associated transcriptomic changes in progressive supranuclear palsy. 

Ressler HW, Humphrey J, Vialle RA, Babrowicz B, Kandoi S, Raj T, Dickson DW, Ertekin-Taner N, Crary JF, Farrell K.

Acta Neuropathol Commun. 2024 Aug 17;12(1):135. doi: 10.1186/s40478-024-01839-3.

PMID: 39154163      Free PMC article.      

62. 

Genomic analysis of intracranial and subcortical brain volumes yields polygenic scores accounting for variation across ancestries. 

Garc a-Mar n LM, Campos AI, Diaz-Torres S, Rabinowitz JA, Ceja Z, Mitchell BL, Grasby KL, Thorp JG, Agartz I, Alhusaini S, Ames D, Amouyel P, Andreassen OA, Arfanakis K, Vasquez AA, Armstrong NJ, Athanasiu L, Bastin ME, Beiser AS, Bennett DA, Bis JC, Boks MP, Boomsma DI, Brodaty H, Brouwer RM, Buitelaar JK, Burkhardt R, Cahn W, Calhoun VD, Carmichael OT, Chakravarty M, Chen Q, Ching CRK, Cichon S, Crespo-Facorro B, Crivello F, Dale AM, Smith GD, de Geus EJ, De Jager PL, de Zubicaray GI, Debette S, DeCarli C, Depondt C, Desrivi res S, Djurovic S, Ehrlich S, Erk S, Espeseth T, Fern ndez G, Filippi I, Fisher SE, Fleischman DA, Fletcher E, Fornage M, Forstner AJ, Francks C, Franke B, Ge T, Goldman AL, Grabe HJ, Green RC, Grimm O, Groenewold NA, Gruber O, Gudnason V, H berg AK, Haukvik UK, Heinz A, Hibar DP, Hilal S, Himali JJ, Ho BC, Hoehn DF, Hoekstra PJ, Hofer E, Hoffmann W, Holmes AJ, Homuth G, Hosten N, Ikram MK, Ipser JC, Jack CR Jr, Jahanshad N, J nsson EG, Kahn RS, Kanai R, Klein M, Knol MJ, Launer LJ, Lawrie SM, Hellard SL, Lee PH, Lema tre H, Li S, Liewald DC, Lin H, Longstreth WT Jr, Lopez OL, Luciano M, Maillard P, Marquand AF, Martin NG, Martinot JL, Mather KA, Mattay VS, McMahon KL, Mecocci P, Melle I, Meyer-Lindenberg A, Mirza-Schreiber N, Milaneschi Y, Mosley TH, M hleisen TW, M ller-Myhsok B, Mu oz Maniega S, Nauck M, Nho K, Niessen WJ, N then MM, Nyquist PA, Oosterlaan J, Pandolfo M, Paus T, Pausova Z, Penninx BW, Pike GB, Psaty BM, P tz B, Reppermund S, Rietschel MD, Risacher SL, Romanczuk-Seiferth N, Romero-Garcia R, Roshchupkin GV, Rotter JI, Sachdev PS, S mann PG, Saremi A, Sargurupremraj M, Saykin AJ, Schmaal L, Schmidt H, Schmidt R, Schofield PR, Scholz M, Schumann G, Schwarz E, Shen L, Shin J, Sisodiya SM, Smith AV, Smoller JW, Soininen HS, Steen VM, Stein DJ, Stein JL, Thomopoulos SI, Toga AW, Tordesillas-Guti rrez D, Trollor JN, Valdes-Hernandez MC, van ‘t Ent D, van Bokhoven H, van der Meer D, van der Wee NJ, V zquez-Bourgon J, Veltman DJ, Vernooij MW, Villringer A, Vinke LN, V lzke H, Walter H, Wardlaw JM, Weinberger DR, Weiner MW, Wen W, Westlye LT, Westman E, White T, Witte AV, Wolf C, Yang J, Zwiers MP, Ikram MA, Seshadri S, Thompson PM, Satizabal CL, Medland SE, Renter a ME.

medRxiv [Preprint]. 2024 Aug 15:2024.08.13.24311922. doi: 10.1101/2024.08.13.24311922.

Update in: Nat Genet. 2024 Nov;56(11):2333-2344. doi: 10.1038/s41588-024-01951-z.

PMID: 39371125      Free PMC article.      Preprint.      

63. 

Alzheimer Disease Cerebrospinal Fluid Biomarkers in a Tertiary Neurology Practice. 

Li W, Petersen RC, Algeciras-Schimnich A, Cogswell PM, Bornhorst JA, Kremers WK, Boeve BF, Jones DT, Botha H, Ramanan VK, Knopman DS, Savica R, Josephs KA, Cliatt-Brown C, Andersen E, Day GS, Graff-Radford NR, Ertekin-Taner N, Lachner C, Wicklund M, van Harten A, Woodruff BK, Caselli RJ, Graff-Radford J.

Mayo Clin Proc. 2024 Aug;99(8):1284-1296. doi: 10.1016/j.mayocp.2023.12.024. Epub 2024 Jun 25.

PMID: 38935019      Free PMC article.      

64. 

Nomination of a novel plasma protein biomarker panel capable of classifying Alzheimer’s disease dementia with high accuracy in an African American cohort. 

Kuchenbecker LA, Thompson KJ, Hurst CD, Opdenbosch BM, Heckman MG, Reddy JS, Nguyen T, Casellas HL, Sotelo KD, Reddy DJ, Lucas JA, Day GS, Willis FB, Graff-Radford N, Ertekin-Taner N, Kalari KR, Carrasquillo MM.

bioRxiv [Preprint]. 2024 Jul 29:2024.07.27.605373. doi: 10.1101/2024.07.27.605373.

PMID: 39131392      Free PMC article.      Preprint.      

65. 

Peripheral inflammation is associated with brain atrophy and cognitive decline linked to mild cognitive impairment and Alzheimer’s disease. 

Liang N, Nho K, Newman JW, Arnold M, Huynh K, Meikle PJ, Borkowski K, Kaddurah-Daouk R; Alzheimer s Disease Metabolomics Consortium.

Sci Rep. 2024 Jul 29;14(1):17423. doi: 10.1038/s41598-024-67177-5.

PMID: 39075118      Free PMC article.      

66. 

Iterative embedding and reweighting of complex networks reveals community structure. 

Kov cs B, Kojaku S, Palla G, Fortunato S.

Sci Rep. 2024 Jul 26;14(1):17184. doi: 10.1038/s41598-024-68152-w.

PMID: 39060433      Free PMC article.      

67. 

Complex patterns of multimorbidity associated with severe COVID-19 and long COVID. 

Pietzner M, Denaxas S, Yasmeen S, Ulmer MA, Nakanishi T, Arnold M, Kastenm ller G, Hemingway H, Langenberg C.

Commun Med (Lond). 2024 Jul 8;4(1):94. doi: 10.1038/s43856-024-00506-x.

PMID: 38977844      Free PMC article.      

68. 

Multiparameter cortical surface morphology in former amateur contact sport athletes. 

Recht G, Hou J, Buddenbaum C, Cheng H, Newman SD, Saykin AJ, Kawata K.

Cereb Cortex. 2024 Jul 3;34(7):bhae301. doi: 10.1093/cercor/bhae301.

PMID: 39077916      Free PMC article.      

69. 

Humanin variant P3S is associated with longevity in APOE4 carriers and resists APOE4-induced brain pathology. 

Miller B, Kim SJ, Cao K, Mehta HH, Thumaty N, Kumagai H, Iida T, McGill C, Pike CJ, Nurmakova K, Levine ZA, Sullivan PM, Yen K, Ertekin-Taner N, Atzmon G, Barzilai N, Cohen P.

Aging Cell. 2024 Jul;23(7):e14153. doi: 10.1111/acel.14153. Epub 2024 Mar 22.

PMID: 38520065      Free PMC article.      

70. 

Gliovascular transcriptional perturbations in Alzheimer’s disease reveal molecular mechanisms of blood brain barrier dysfunction. 

İş , Wang X, Reddy JS, Min Y, Yilmaz E, Bhattarai P, Patel T, Bergman J, Quicksall Z, Heckman MG, Tutor-New FQ, Can Demirdogen B, White L, Koga S, Krause V, Inoue Y, Kanekiyo T, Cosacak MI, Nelson N, Lee AJ, Vardarajan B, Mayeux R, Kouri N, Deniz K, Carnwath T, Oatman SR, Lewis-Tuffin LJ, Nguyen T; Alzheimer s Disease Neuroimaging Initiative; Carrasquillo MM, Graff-Radford J, Petersen RC, Jr Jack CR, Kantarci K, Murray ME, Nho K, Saykin AJ, Dickson DW, Kizil C, Allen M, Ertekin-Taner N.

Nat Commun. 2024 Jun 20;15(1):4758. doi: 10.1038/s41467-024-48926-6.

PMID: 38902234      Free PMC article.      

71. 

Sex, racial, and APOE-ε4 allele differences in longitudinal white matter microstructure in multiple cohorts of aging and Alzheimer’s disease. 

Peterson A, Sathe A, Zaras D, Yang Y, Durant A, Deters KD, Shashikumar N, Pechman KR, Kim ME, Gao C, Khairi NM, Li Z, Yao T, Huo Y, Dumitrescu L, Gifford KA, Wilson JE, Cambronero F, Risacher SL, Beason-Held LL, An Y, Arfanakis K, Erus G, Davatzikos C, Tosun D, Toga AW, Thompson PM, Mormino EC, Zhang P, Schilling K; Alzheimer s Disease Neuroimaging Initiative (ADNI); BIOCARD Study Team; Alzheimer s Disease Sequencing Project (ADSP); Albert M, Kukull W, Biber SA, Landman BA, Johnson SC, Schneider J, Barnes LL, Bennett DA, Jefferson AL, Resnick SM, Saykin AJ, Hohman TJ, Archer DB.

bioRxiv [Preprint]. 2024 Jun 12:2024.06.10.598357. doi: 10.1101/2024.06.10.598357.

Update in: Alzheimers Dement. 2025 Jan;21(1):e14343. doi: 10.1002/alz.14343.

PMID: 38915636      Free PMC article.      Preprint.      

72. 

Associations among plasma, MRI, and amyloid PET biomarkers of Alzheimer’s disease and related dementias and the impact of health-related comorbidities in a community-dwelling cohort. 

Rudolph MD, Sutphen CL, Register TC, Whitlow CT, Solingapuram Sai KK, Hughes TM, Bateman JR, Dage JL, Russ KA, Mielke MM, Craft S, Lockhart SN.

Alzheimers Dement. 2024 Jun;20(6):4159-4173. doi: 10.1002/alz.13835. Epub 2024 May 15.

PMID: 38747525      Free PMC article.      

73. 

Clinicopathologic Heterogeneity and Glial Activation Patterns in Alzheimer Disease. 

Kouri N, Frankenhauser I, Peng Z, Labuzan SA, Boon BDC, Moloney CM, Pottier C, Wickland DP, Caetano-Anolles K, Corriveau-Lecavalier N, Tranovich JF, Wood AC, Hinkle KM, Lincoln SJ, Spychalla AJ, Senjem ML, Przybelski SA, Engelberg-Cook E, Schwarz CG, Kwan RS, Lesser ER, Crook JE, Carter RE, Ross OA, Lachner C, Ertekin-Taner N, Ferman TJ, Fields JA, Machulda MM, Ramanan VK, Nguyen AT, Reichard RR, Jones DT, Graff-Radford J, Boeve BF, Knopman DS, Petersen RC, Jack CR Jr, Kantarci K, Day GS, Duara R, Graff-Radford NR, Dickson DW, Lowe VJ, Vemuri P, Murray ME.

JAMA Neurol. 2024 Jun 1;81(6):619-629. doi: 10.1001/jamaneurol.2024.0784.

PMID: 38619853      Free PMC article.      

74. 

Large-scale Deep Proteomic Analysis in Alzheimer’s Disease Brain Regions Across Race and Ethnicity. 

Seifar F, Fox EJ, Shantaraman A, Liu Y, Dammer EB, Modeste E, Duong DM, Yin L, Trautwig AN, Guo Q, Xu K, Ping L, Reddy JS, Allen M, Quicksall Z, Heath L, Scanlan J, Wang E, Wang M, Linden AV, Poehlman W, Chen X, Baheti S, Ho C, Nguyen T, Yepez G, Mitchell AO, Oatman SR, Wang X, Carrasquillo MM, Runnels A, Beach T, Serrano GE, Dickson DW, Lee EB, Golde TE, Prokop S, Barnes LL, Zhang B, Haroutunian V, Gearing M, Lah JJ, Jager P, Bennett DA, Greenwood A, Ertekin-Taner N, Levey AI, Wingo A, Wingo T, Seyfried NT.

bioRxiv [Preprint]. 2024 Apr 26:2024.04.22.590547. doi: 10.1101/2024.04.22.590547.

Update in: Alzheimers Dement. 2024 Dec;20(12):8878-8897. doi: 10.1002/alz.14360.

PMID: 38712030      Free PMC article.      Preprint.      

75. 

Rare genetic variation in fibronectin 1 (FN1) protects against APOEε4 in Alzheimer’s disease. 

Bhattarai P, Gunasekaran TI, Belloy ME, Reyes-Dumeyer D, J lich D, Tayran H, Yilmaz E, Flaherty D, Turgutalp B, Sukumar G, Alba C, McGrath EM, Hupalo DN, Bacikova D, Le Guen Y, Lantigua R, Medrano M, Rivera D, Recio P, Nuriel T, Ertekin-Taner N, Teich AF, Dickson DW, Holley S, Greicius M, Dalgard CL, Zody M, Mayeux R, Kizil C, Vardarajan BN.

Acta Neuropathol. 2024 Apr 10;147(1):70. doi: 10.1007/s00401-024-02721-1.

PMID: 38598053      Free PMC article.      

76. 

Role of GBA variants in Lewy body disease neuropathology. 

Walton RL, Koga S, Beasley AI, White LJ, Griesacker T, Murray ME, Kasanuki K, Hou X, Fiesel FC, Springer W, Uitti RJ, Fields JA, Botha H, Ramanan VK, Kantarci K, Lowe VJ, Jack CR, Ertekin-Taner N, Savica R, Graff-Radford J, Petersen RC, Parisi JE, Reichard RR, Graff-Radford NR, Ferman TJ, Boeve BF, Wszolek ZK, Dickson DW, Ross OA, Heckman MG.

Acta Neuropathol. 2024 Mar 12;147(1):54. doi: 10.1007/s00401-024-02699-w.

PMID: 38472443      Free PMC article.      

77. 

Harnessing diversity to study Alzheimer’s disease: A new iPSC resource from the NIH CARD and ADNI. 

Screven LA, Pantazis CB, Andersh KM, Hong S, Vitale D, Lara E, Ku RY, Heutink P, Meyer J, Faber K, Nho K, Saykin AJ, Foroud TM, Nalls MA, Blauwendraat C, Singleton A, Narayan PS.

Neuron. 2024 Mar 6;112(5):694-697. doi: 10.1016/j.neuron.2024.01.026. Epub 2024 Feb 21.

PMID: 38387456      Free PMC article.      

78. 

Spatial transcriptomic patterns underlying amyloid-β and tau pathology are associated with cognitive dysfunction in Alzheimer’s disease. 

Yu M, Risacher SL, Nho KT, Wen Q, Oblak AL, Unverzagt FW, Apostolova LG, Farlow MR, Brosch JR, Clark DG, Wang S, Deardorff R, Wu YC, Gao S, Sporns O, Saykin AJ; Alzheimer s Disease Neuroimaging Initiative (ADNI).

Cell Rep. 2024 Feb 27;43(2):113691. doi: 10.1016/j.celrep.2024.113691. Epub 2024 Jan 19.

PMID: 38244198      Free PMC article.      

79. 

The Rise of Hypothesis-Driven Artificial Intelligence in Oncology. 

Xianyu Z, Correia C, Ung CY, Zhu S, Billadeau DD, Li H.

Cancers (Basel). 2024 Feb 18;16(4):822. doi: 10.3390/cancers16040822.

PMID: 38398213      Free PMC article.      Review.      

80. 

Deciphering the tissue-specific functional effect of Alzheimer risk SNPs with deep genome annotation. 

Pugalenthi PV, He B, Xie L, Nho K, Saykin AJ, Yan J.

Res Sq [Preprint]. 2024 Feb 8:rs.3.rs-3871665. doi: 10.21203/rs.3.rs-3871665/v1.

Update in: BioData Min. 2024 Nov 13;17(1):50. doi: 10.1186/s13040-024-00400-1.

PMID: 38405816      Free PMC article.      Preprint.      

81. 

QOT: Efficient Computation of Sample Level Distance Matrix from Single-Cell Omics Data through Quantized Optimal Transport. 

Wang Z, Zhan Q, Yang S, Mu S, Chen J, Garai S, Orzechowski P, Wagenaar J, Shen L.

bioRxiv [Preprint]. 2024 Feb 6:2024.02.06.578032. doi: 10.1101/2024.02.06.578032.

Update in: Brief Bioinform. 2024 Nov 22;26(1):bbae713. doi: 10.1093/bib/bbae713.

PMID: 38370767      Free PMC article.      Preprint.      

82. 

Edge time series components of functional connectivity and cognitive function in Alzheimer’s disease. 

Chumin EJ, Cutts SA, Risacher SL, Apostolova LG, Farlow MR, McDonald BC, Wu YC, Betzel R, Saykin AJ, Sporns O.

Brain Imaging Behav. 2024 Feb;18(1):243-255. doi: 10.1007/s11682-023-00822-1. Epub 2023 Nov 27.

PMID: 38008852      Free PMC article.      

83. 

miR-129-5p as a biomarker for pathology and cognitive decline in Alzheimer’s disease. 

Han SW, Pyun JM, Bice PJ, Bennett DA, Saykin AJ, Kim SY, Park YH, Nho K.

Alzheimers Res Ther. 2024 Jan 9;16(1):5. doi: 10.1186/s13195-023-01366-8.

PMID: 38195609      Free PMC article.      

84. 

Cryptic splicing of stathmin-2 and UNC13A mRNAs is a pathological hallmark of TDP-43-associated Alzheimer’s disease. 

Agra Almeida Quadros AR, Li Z, Wang X, Ndayambaje IS, Aryal S, Ramesh N, Nolan M, Jayakumar R, Han Y, Stillman H, Aguilar C, Wheeler HJ, Connors T, Lopez-Erauskin J, Baughn MW, Melamed Z, Beccari MS, Olmedo Mart nez L, Canori M, Lee CZ, Moran L, Draper I, Kopin AS, Oakley DH, Dickson DW, Cleveland DW, Hyman BT, Das S, Ertekin-Taner N, Lagier-Tourenne C.

Acta Neuropathol. 2024 Jan 4;147(1):9. doi: 10.1007/s00401-023-02655-0.

PMID: 38175301      Free PMC article.      

85. 

Fairness-Aware Estimation of Graphical Models. 

Zhou Z, Tarzanagh DA, Hou B, Long Q, Shen L.

Adv Neural Inf Process Syst. 2024;37:17870-17909.

PMID: 40855882      Free PMC article.      

86. 

Does the Cognitive Change Index Predict Future Cognitive and Clinical Decline? Longitudinal Analysis in a Demographically Diverse Cohort. 

Nester CO, Gao Q, Katz MJ, Mogle JA, Wang C, Derby CA, Lipton RB, Saykin AJ, Rabin LA.

J Alzheimers Dis. 2024;98(1):319-332. doi: 10.3233/JAD-230752.

PMID: 38393900      Free PMC article.      

87. 

Multiorgan locked-state model of chronic diseases and systems pharmacology opportunities. 

Ung CY, Correia C, Li H, Adams CM, Westendorf JJ, Zhu S.

Drug Discov Today. 2024 Jan;29(1):103825. doi: 10.1016/j.drudis.2023.103825. Epub 2023 Nov 13.

PMID: 37967790      Free PMC article.      Review.      

88. 

Transcriptional risk scores in Alzheimer’s disease: From pathology to cognition. 

Pyun JM, Park YH, Wang J, Bennett DA, Bice PJ, Kim JP, Kim S, Saykin AJ, Nho K.

Alzheimers Dement. 2024 Jan;20(1):243-252. doi: 10.1002/alz.13406. Epub 2023 Aug 10.

PMID: 37563770      Free PMC article.      

89. 

Aβ Amyloid Scaffolds the Accumulation of Matrisome and Additional Proteins in Alzheimer’s Disease. 

Levites Y, Dammer EB, Ran Y, Tsering W, Duong D, Abreha M, Gadhavi J, Lolo K, Trejo-Lopez J, Phillips JL, Iturbe A, Erqiuzi A, Moore BD, Ryu D, Natu A, Dillon KD, Torrellas J, Moran C, Ladd TB, Afroz KF, Islam T, Jagirdar J, Funk CC, Robinson M, Borchelt DR, Ertekin-Taner N, Kelly JW, Heppner FL, Johnson EC, McFarland K, Levey AL, Prokop S, Seyfried NT, Golde TE.

bioRxiv [Preprint]. 2023 Dec 7:2023.11.29.568318. doi: 10.1101/2023.11.29.568318.

Update in: Cell Rep Med. 2024 Aug 20;5(8):101669. doi: 10.1016/j.xcrm.2024.101669.

PMID: 38076912      Free PMC article.      Preprint.      

90. 

BrainAGE Estimation: Influence of Field Strength, Voxel Size, Race, and Ethnicity. 

Dempsey DA, Deardorff R, Wu YC, Yu M, Apostolova LG, Brosch J, Clark DG, Farlow MR, Gao S, Wang S, Saykin AJ, Risacher SL; Alzheimer s Disease Neuroimaging Initiative.

medRxiv [Preprint]. 2023 Dec 5:2023.12.05.23299222. doi: 10.1101/2023.12.05.23299222.

PMID: 38106123      Free PMC article.      Preprint.      

91. 

Cross species systems biology discovers glial DDR2, STOM, and KANK2 as therapeutic targets in progressive supranuclear palsy. 

Min Y, Wang X, İş , Patel TA, Gao J, Reddy JS, Quicksall ZS, Nguyen T, Lin S, Tutor-New FQ, Chalk JL, Mitchell AO, Crook JE, Nelson PT, Van Eldik LJ, Golde TE, Carrasquillo MM, Dickson DW, Zhang K, Allen M, Ertekin-Taner N.

Nat Commun. 2023 Nov 2;14(1):6801. doi: 10.1038/s41467-023-42626-3.

PMID: 37919278      Free PMC article.      

92. 

miR-129-5p as a biomarker for pathology and cognitive decline in Alzheimer’s disease. 

Han SW, Pyun JM, Bice PJ, Bennett DA, Saykin AJ, Kim S, Park YH, Nho K.

Res Sq [Preprint]. 2023 Nov 1:rs.3.rs-3501125. doi: 10.21203/rs.3.rs-3501125/v1.

Update in: Alzheimers Res Ther. 2024 Jan 9;16(1):5. doi: 10.1186/s13195-023-01366-8.

PMID: 37961387      Free PMC article.      Preprint.      

93. 

Genome-Wide Association Analysis across Endophenotypes in Alzheimer’s Disease: Main Effects and Disease Stage-Specific Interactions. 

Rosewood TJ, Nho K, Risacher SL, Gao S, Shen L, Foroud T, Saykin AJ, On Behalf Of The Alzheimer’s Disease Neuroimaging Initiative.

Genes (Basel). 2023 Oct 27;14(11):2010. doi: 10.3390/genes14112010.

PMID: 38002954      Free PMC article.      

94. 

Association of Plasma Biomarkers of Alzheimer Disease With Cognition and Medical Comorbidities in a Biracial Cohort. 

Ramanan VK, Graff-Radford J, Syrjanen J, Shir D, Algeciras-Schimnich A, Lucas J, Martens YA, Carrasquillo MM, Day GS, Ertekin-Taner N, Lachner C, Willis FB, Knopman DS, Jack CR Jr, Petersen RC, Vemuri P, Graff-Radford N, Mielke MM.

Neurology. 2023 Oct 3;101(14):e1402-e1411. doi: 10.1212/WNL.0000000000207675. Epub 2023 Aug 14.

PMID: 37580163      Free PMC article.      

95. 

Retrospective Evaluation of Neuropathologic Proxies of the Minimal Atrophy Subtype Compared With Corticolimbic Alzheimer Disease Subtypes. 

Boon BDC, Labuzan SA, Peng Z, Matchett BJ, Kouri N, Hinkle KM, Lachner C, Ross OA, Ertekin-Taner N, Carter RE, Ferman TJ, Duara R, Dickson DW, Graff-Radford NR, Murray ME.

Neurology. 2023 Oct 3;101(14):e1412-e1423. doi: 10.1212/WNL.0000000000207685. Epub 2023 Aug 14.

PMID: 37580158      Free PMC article.      

96. 

Preference matrix guided sparse canonical correlation analysis for mining brain imaging genetic associations in Alzheimer’s disease. 

Sha J, Bao J, Liu K, Yang S, Wen Z, Wen J, Cui Y, Tong B, Moore JH, Saykin AJ, Davatzikos C, Long Q, Shen L; Alzheimer’s Disease Neuroimaging Initiative.

Methods. 2023 Oct;218:27-38. doi: 10.1016/j.ymeth.2023.07.007. Epub 2023 Jul 27.

PMID: 37507059      Free PMC article.      

97. 

Amyloid and tau pathology are associated with cerebral blood flow in a mixed sample of nondemented older adults with and without vascular risk factors for Alzheimer’s disease. 

Swinford CG, Risacher SL, Vosmeier A, Deardorff R, Chumin EJ, Dzemidzic M, Wu YC, Gao S, McDonald BC, Yoder KK, Unverzagt FW, Wang S, Farlow MR, Brosch JR, Clark DG, Apostolova LG, Sims J, Wang DJ, Saykin AJ.

Neurobiol Aging. 2023 Oct;130:103-113. doi: 10.1016/j.neurobiolaging.2023.06.014. Epub 2023 Jun 28.

PMID: 37499587      Free PMC article.      

98. 

APOE ε4 influences within and between network functional connectivity in posterior cortical atrophy and logopenic progressive aphasia. 

Singh NA, Martin PR, Graff-Radford J, Machulda MM, Carrasquillo MM, Ertekin-Taner N, Josephs KA, Whitwell JL.

Alzheimers Dement. 2023 Sep;19(9):3858-3866. doi: 10.1002/alz.13059. Epub 2023 Mar 31.

PMID: 36999481      Free PMC article.      

99. 

Single-nucleus multiomic mapping of m6A methylomes and transcriptomes in native populations of cells with sn-m6A-CT. 

Hamashima K, Wong KW, Sam TW, Teo JHJ, Taneja R, Le MTN, Li QJ, Hanna JH, Li H, Loh YH.

Mol Cell. 2023 Aug 25:S1097-2765(23)00649-4. doi: 10.1016/j.molcel.2023.08.010. Online ahead of print.

PMID: 37657444      Free PMC article.      

100. 

APOE deficiency impacts neural differentiation and cholesterol biosynthesis in human iPSC-derived cerebral organoids. 

Zhao J, Ikezu TC, Lu W, Macyczko JR, Li Y, Lewis-Tuffin LJ, Martens YA, Ren Y, Zhu Y, Asmann YW, Ertekin-Taner N, Kanekiyo T, Bu G.

Stem Cell Res Ther. 2023 Aug 21;14(1):214. doi: 10.1186/s13287-023-03444-y.

PMID: 37605285      Free PMC article.      

101. 

Comparative brain metabolomics reveals shared and distinct metabolic alterations in Alzheimer’s disease and progressive supranuclear palsy. 

Batra R, Krumsiek J, Wang X, Allen M, Blach C, Kastenm ller G, Arnold M, Ertekin-Taner N, Kaddurah-Daouk RF; Alzheimer s Disease Metabolomics Consortium (ADMC).

medRxiv [Preprint]. 2023 Jul 27:2023.07.25.23293055. doi: 10.1101/2023.07.25.23293055.

Update in: Alzheimers Dement. 2024 Dec;20(12):8294-8307. doi: 10.1002/alz.14249.

PMID: 37546878      Free PMC article.      Preprint.      

102. 

Nerve growth factor receptor (Ngfr) induces neurogenic plasticity by suppressing reactive astroglial Lcn2/Slc22a17 signaling in Alzheimer’s disease. 

Siddiqui T, Cosacak MI, Popova S, Bhattarai P, Yilmaz E, Lee AJ, Min Y, Wang X, Allen M, İş , Atasavum ZT, Rodriguez-Muela N, Vardarajan BN, Flaherty D, Teich AF, Santa-Maria I, Freudenberg U, Werner C, Tosto G, Mayeux R, Ertekin-Taner N, Kizil C.

NPJ Regen Med. 2023 Jul 10;8(1):33. doi: 10.1038/s41536-023-00311-5.

PMID: 37429840      Free PMC article.      

103. 

Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies LRRC4C, LHX5-AS1 and nominates ancestry-specific loci PTPRK , GRB14 , and KIAA0825 as novel risk loci for Alzheimer’s disease: the Alzheimer’s Disease Genetics Consortium. 

Rajabli F, Benchek P, Tosto G, Kushch N, Sha J, Bazemore K, Zhu C, Lee WP, Haut J, Hamilton-Nelson KL, Wheeler NR, Zhao Y, Farrell JJ, Grunin MA, Leung YY, Kuksa PP, Li D, Lucio da Fonseca E, Mez JB, Palmer EL, Pillai J, Sherva RM, Song YE, Zhang X, Iqbal T, Pathak O, Valladares O, Kuzma AB, Abner E, Adams PM, Aguirre A, Albert MS, Albin RL, Allen M, Alvarez L, Apostolova LG, Arnold SE, Asthana S, Atwood CS, Ayres G, Baldwin CT, Barber RC, Barnes LL, Barral S, Beach TG, Becker JT, Beecham GW, Beekly D, Benitez BA, Bennett D, Bertelson J, Bird TD, Blacker D, Boeve BF, Bowen JD, Boxer A, Brewer J, Burke JR, Burns JM, Buxbaum JD, Cairns NJ, Cantwell LB, Cao C, Carlson CS, Carlsson CM, Carney RM, Carrasquillo MM, Chasse S, Chesselet MF, Chin NA, Chui HC, Chung J, Craft S, Crane PK, Cribbs DH, Crocco EA, Cruchaga C, Cuccaro ML, Cullum M, Darby E, Davis B, De Jager PL, DeCarli C, DeToledo J, Dick M, Dickson DW, Dombroski BA, Doody RS, Duara R, Ertekin-Taner N, Evans DA, Faber KM, Fairchild TJ, Fallon KB, Fardo DW, Farlow MR, Fernandez-Hernandez V, Ferris S, Foroud TM, Frosch MP, Fulton-Howard B, Galasko DR, Gamboa A, Gearing M, Geschwind DH, Ghetti B, Gilbert JR, Goate AM, Grabowski TJ, Graff-Radford NR, Green RC, Growdon JH, Hakonarson H, Hall J, Hamilton RL, Harari O, Hardy J, Harrell LE, Head E, Henderson VW, Hernandez M, Hohman T, Honig LS, Huebinger RM, Huentelman MJ, Hulette CM, Hyman BT, Hynan LS, Ibanez L, Jarvik GP, Jayadev S, Jin LW, Johnson K, Johnson L, Kamboh MI, Karydas AM, Katz MJ, Kauwe JS, Kaye JA, Keene CD, Khaleeq A, Kim R, Knebl J, Kowall NW, Kramer JH, Kukull WA, LaFerla FM, Lah JJ, Larson EB, Lerner A, Leverenz JB, Levey AI, Lieberman AP, Lipton RB, Logue M, Lopez OL, Lunetta KL, Lyketsos CG, Mains D, Margaret FE, Marson DC, Martin ERR, Martiniuk F, Mash DC, Masliah E, Massman P, Masurkar A, McCormick WC, McCurry SM, McDavid AN, McDonough S, McKee AC, Mesulam M, Miller BL, Miller CA, Miller JW, Montine TJ, Monuki ES, Morris JC, Mukherjee S, Myers AJ, Nguyen T, O’Bryant S, Olichney JM, Ory M, Palmer R, Parisi JE, Paulson HL, Pavlik V, Paydarfar D, Perez V, Peskind E, Petersen RC, Pierce A, Polk M, Poon WW, Potter H, Qu L, Quiceno M, Quinn JF, Raj A, Raskind M, Reiman EM, Reisberg B, Reisch JS, Ringman JM, Roberson ED, Rodriguear M, Rogaeva E, Rosen HJ, Rosenberg RN, Royall DR, Sager MA, Sano M, Saykin AJ, Schneider JA, Schneider LS, Seeley WW, Slifer SH, Small S, Smith AG, Smith JP, Sonnen JA, Spina S, St George-Hyslop P, Stern RA, Stevens AB, Strittmatter SM, Sultzer D, Swerdlow RH, Tanzi RE, Tilson JL, Trojanowski JQ, Troncoso JC, Tsuang DW, Van Deerlin VM, van Eldik LJ, Vance JM, Vardarajan BN, Vassar R, Vinters HV, Vonsattel JP, Weintraub S, Welsh-Bohmer KA, Whitehead PL, Wijsman EM, Wilhelmsen KC, Williams B, Williamson J, Wilms H, Wingo TS, Wisniewski T, Woltjer RL, Woon M, Wright CB, Wu CK, Younkin SG, Yu CE, Yu L, Zhu X, Kunkle BW, Bush WS, Wang LS, Farrer LA, Haines JL, Mayeux R, Pericak-Vance MA, Schellenberg GD, Jun GR, Reitz C, Naj AC.

medRxiv [Preprint]. 2023 Jul 8:2023.07.06.23292311. doi: 10.1101/2023.07.06.23292311.

PMID: 37461624      Free PMC article.      Preprint.      

104. 

Image harmonization: A review of statistical and deep learning methods for removing batch effects and evaluation metrics for effective harmonization. 

Hu F, Chen AA, Horng H, Bashyam V, Davatzikos C, Alexander-Bloch A, Li M, Shou H, Satterthwaite TD, Yu M, Shinohara RT.

Neuroimage. 2023 Jul 1;274:120125. doi: 10.1016/j.neuroimage.2023.120125. Epub 2023 Apr 20.

PMID: 37084926      Free PMC article.      Review.      

105. 

The SERPINA5 coding variant E228Q does not contribute to clinicopathologic characteristics in Alzheimer’s disease: A cross-sectional study. 

Matchett BJ, Lincoln SJ, Baker M, Tamvaka N, Labuzan SA, Hicks Sirmans TN, Moloney CM, Helminger J, Hinkle KM, Cabrera-Rodriguez J, Wickland DP, Johnson PW, Heckman MG, Reddy JS, Younkin SG, Carrasquillo MM, Duara R, Graff-Radford NR, Pottier C, Ertekin-Taner N, Ross OA, Rademakers R, Dickson DW, Murray ME.

Medicine (Baltimore). 2023 Jun 16;102(24):e34017. doi: 10.1097/MD.0000000000034017.

PMID: 37327267      Free PMC article.      

106. 

Predictive network analysis identifies JMJD6 and other potential key drivers in Alzheimer’s disease. 

Merchant JP, Zhu K, Henrion MYR, Zaidi SSA, Lau B, Moein S, Alamprese ML, Pearse RV 2nd, Bennett DA, Ertekin-Taner N, Young-Pearse TL, Chang R.

Commun Biol. 2023 May 15;6(1):503. doi: 10.1038/s42003-023-04791-5.

PMID: 37188718      Free PMC article.      

107. 

Aberrant GAP43 Gene Expression Is Alzheimer Disease Pathology-Specific. 

Pyun JM, Park YH, Wang J, Bice PJ, Bennett DA, Kim S, Saykin AJ, Nho K.

Ann Neurol. 2023 May;93(5):1047-1048. doi: 10.1002/ana.26637. Epub 2023 Mar 21.

PMID: 36897291      Free PMC article.      No abstract available.

108. 

Clinicopathological associations of hemispheric dominance in primary progressive apraxia of speech. 

Robinson CG, Duffy JR, Clark HA, Utianski RL, Machulda MM, Botha H, Singh NA, Pham NTT, Ertekin-Taner N, Dickson DW, Lowe VJ, Whitwell JL, Josephs KA.

Eur J Neurol. 2023 May;30(5):1209-1219. doi: 10.1111/ene.15764. Epub 2023 Mar 15.

PMID: 36869612      Free PMC article.      

109. 

White matter integrity is associated with cognition and amyloid burden in older adult Koreans along the Alzheimer’s disease continuum. 

Hirschfeld LR, Deardorff R, Chumin EJ, Wu YC, McDonald BC, Cao S, Risacher SL, Yi D, Byun MS, Lee JY, Kim YK, Kang KM, Sohn CH, Nho K, Saykin AJ, Lee DY; KBASE Research Group.

medRxiv [Preprint]. 2023 Apr 6:2023.04.05.23288147. doi: 10.1101/2023.04.05.23288147.

Update in: Alzheimers Res Ther. 2023 Dec 16;15(1):218. doi: 10.1186/s13195-023-01369-5.

PMID: 37066317      Free PMC article.      Preprint.      

110. 

Novel CYP1B1-RMDN2 Alzheimer’s disease locus identified by genome-wide association analysis of cerebral tau deposition on PET. 

Nho K, Risacher SL, Apostolova L, Bice PJ, Brosch J, Deardorff R, Faber K, Farlow MR, Foroud T, Gao S, Rosewood T, Kim JP, Nudelman K, Yu M, Aisen P, Sperling R, Hooli B, Shcherbinin S, Svaldi D, Jack CR, Jagust WJ, Landau S, Vasanthakumar A, Waring JF, Dor V, Laws SM, Masters CL, Porter T, Rowe CC, Villemagne VL, Dumitrescu L, Hohman TJ, Libby JB, Mormino E, Buckley RF, Johnson K, Yang HS, Petersen RC, Ramanan VK, Vemuri P, Cohen AD, Fan KH, Kamboh MI, Lopez OL, Bennett DA, Ali M, Benzinger T, Cruchaga C, Hobbs D, De Jager PL, Fujita M, Jadhav V, Lamb BT, Tsai AP, Castanho I, Mill J, Weiner MW; Alzheimer s Disease Neuroimaging Initiative (ADNI); Alzheimer s Disease Neuroimaging Initiative Department of Defense; Anti-Amyloid Treatment in Asymptomatic Alzheimer s Study (A4 Study); Australian Imaging, Biomarker & Lifestyle Study (AIBL); Saykin AJ.

medRxiv [Preprint]. 2023 Mar 22:2023.02.27.23286048. doi: 10.1101/2023.02.27.23286048.

PMID: 36993271      Free PMC article.      Preprint.